• Social Media Insights Company Launches App for Social Listening

    Clinical Informatics News | Treato, a social media insights company that describes itself as the world’s largest “patient voice” source, has announced it will apply its big data infrastructure and technology to social media networks, giving patients a platform to discuss treatments and allowing the medical and business communities to gauge real-time patient attitudes, view social trends, and gain insights into their—and their competitors’—advertisements and products.

    Jul 6, 2015

  • Sequenced at Birth

    MIT Technology Review | BabySeq, a study examining the health outcomes of sequencing newborns' genomes, has enrolled its first four subjects at Boston hospitals.

    Jul 2, 2015

  • June Clinical News and Product Briefs

    Clinical Informatics News | Clinical news and product briefs from around the industry, including a host of new trial management solutions unveiled at DIA 2015.

    Jul 1, 2015

  • IMS Health to Acquire ViS Research

    Clinical Informatics News Brief | IMS Health tweeted out news of its acquisition of ViS Research last week during the DIA annual meeting. 

    Jun 24, 2015

  • A Bill Would Prevent Drug Makers From Frustrating Generic Rivals

    WSJ | A pair of lawmakers has reintroduced a bill designed to end a practice that generic drug makers complain is used by brand-name counterparts to thwart competition.

    Jun 23, 2015

  • New Board Chairman Jeffrey Kasher Bringing Speed to DrugDev

    Clinical Informatics News | DrugDev, a provider of cloud-based solutions for clinical trials, has tapped Jeffrey Kasher, Ph.D., as Chairman of the Advisory Board.  

    Jun 22, 2015

  • Telemedicine Study Looks at Quality of Care for Parkinson’s Patients

    Clinical Informatics News | The National Parkinson Foundation and University of Rochester researchers are collaborating on a year-long study comparing the efficacy of telemedicine to in-person community care and updating the term "house call" for the 21st century.

    Jun 18, 2015

  • Why Hasn't Big Data Come to the Rescue in Clinical Data Unification?

    Clinical Informatics News | Contributed Commentary | The cost-to-value equation for standardizing clinical data is broken. Pharmaceutical companies spend millions of dollars annually, and substantially delay products’ time to market, sending clinical data to contractors for preparation and integration before analysis. A complete view of all available clinical data would be incredibly useful for improving clinical analytics, simplifying cross-study comparisons, speeding future trials, and data mining for new indications. 

    Jun 17, 2015

  • Mobile Data Collection’s Role in the Clinical Trial of the Future

    mobihealthnews | Craig Lipset talks about the mobile clinical trial that failed, why, and what we can do moving forward.

    Jun 17, 2015

  • FDA taps PatientsLikeMe to test the waters of social media adverse event reporting

    mobihealthnews | PatientsLikeMe has announced a research partnership with the FDA: The agency will assess the platform's feasibility as a way to generate adverse event reports, which the FDA uses to regulate drugs after their release into the market.

    Jun 16, 2015

  • The Confidential Reasons Drugs Are Rejected by the FDA

    Clinical Informatics News | The FDA has published a study to assess whether its reasons for rejecting drugs and medical devices — currently kept confidential unless the sponsors of trials choose to release them — are effectively reaching the public, concluding that there are stark discrepancies between what the FDA tells companies about their products and what those companies report in public.

    Jun 15, 2015

  • Foundation Medicine Connects Mutations, Treatment Plans for Personalized Care

    Clinical Informatics News | Foundation Medicine has launched PatientMatch, a tool to connect doctors who are treating patients with similar rare genetic mutations. At Sarah Cannon Research Institute, physicians are finding it useful for connecting patients to the right drug trials as well.

    Jun 12, 2015

  • Stanford Pharmacovigilance Program Suggests New Drug Risks

    Washington Post | A project by scientists at Stanford University to monitor a large set of electronic health records has uncovered a probable link between extended use of proton pump inhibitors, including Nexium and Prilosec, and an increased risk of heart attack.

    Jun 11, 2015